Clinical Trials Directory

Trials / Completed

CompletedNCT03232957

Intrathecal Morphine for Unilateral Total Knee Arthroplasty

Efficacy and Side Effects of Intrathecal Morphine in Multimodal Analgesia for Unilateral Total Knee Arthroplasty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
131 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study evaluates postoperative numerical pain score and systemic opioid requirement within 48 hours for unilateral total knee arthroplasty. Comparing among 3 groups of intrathecal morphine; 0,50, 100 ug with multimodal analgesia.

Detailed description

Intrathecal opioid is effective postoperative analgesia for orthopedic lower extremity surgery. However there are some limitations such as nausea, vomiting, pruritus, dizziness. Nowadays multimodal analgesia is used in unilateral total knee arthroplasty include oral analgesic drugs, adductor canal block and local analgesia infiltration. This study evaluates whether intrathecal opioid should be added in the role of multimodal analgesia in total knee arthroplasty.

Conditions

Interventions

TypeNameDescription
PROCEDURE50 ug IT morphineSpinal block with bupivacaine and intrathecal morphine 50 ug
PROCEDURE100 ug IT morphineSpinal block with bupivacaine and intrathecal morphine 100 ug
PROCEDURENo IT morphineSpinal block with bupivacaine and intrathecal morphine 0 ug
DRUGMorphineintrathecal morphine
DRUGBupivacaine0.5 isobaric bupivacaine

Timeline

Start date
2017-08-01
Primary completion
2019-02-01
Completion
2019-07-31
First posted
2017-07-28
Last updated
2021-05-24

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03232957. Inclusion in this directory is not an endorsement.